Akitoshi Nakayama   Masataka Yokoyama   Hidekazu Nagano   Ikki Sakuma   Naoko Hashimoto   Seiichiro Higuchi   Kazuyuki Yamagata   Tomoaki Tanaka   
Journal of the Endocrine Society 4(Supplement_1) 2020年5月
<title>Abstract</title>
p53 is mutated more than half of human cancers, and mutant p53, a gain of function, can actively have functional consequences with tumorigenesis. However, its action of molecular mechanisms, particularly in vivo conditions...